Streptococcus pneumoniae Vakzine

European patent · EP2384765 · In force

Register entry

Publication number
EP2384765
Application number
EP10192663
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 20, 2006
Published
Nov 9, 2011
Granted
Nov 23, 2016
Protection ends at the latest
Dec 19, 2026
Next annual fee due
Dec 31, 2026
IPC classes
A61K 39/09 (2006.01)
Priority
GB 0526232 22.12.2005
GB 0607087 07.04.2006
GB 0607088 07.04.2006
GB 0609902 18.05.2006
GB 0620336 12.10.2006
GB 0620337 12.10.2006
GB 0620815 19.10.2006
GB 0620816 19.10.2006
WO PCT/GB2006/004634 12.12.2006
Divided from
EP06830743
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Jan 1, 2023

    Change

    Published in Swissreg on 01.01.2023

  5. Dec 1, 2016

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 01.12.2016

  6. Nov 23, 2016

    Granted

    Published in Swissreg on 23.11.2016

Parties

Holder

GlaxoSmithKline Biologicals S.A.

Rue de l'Institut, 89, 1330 Rixensart, BE

Agent

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventor

Biemans, Ralph Leon

1330 Rixensart, BE

Garcon, Nathalie Marie-Josephe

1330 Rixensart, BE

Hermand, Philippe Vincent

1330 Rixensart, BE

Poolman, Jan

1330 Rixensart, BE

Van Mechelen, Marcelle Paulette

1330 Rixensart, BE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.